BofA update shows where active managers are putting money
Investing.com - Bernstein SocGen Group reiterated its Market Perform rating and $125.00 price target on Agilent (NYSE:A) on Thursday, citing strong organic growth that signals continued market recovery. According to InvestingPro data, Agilent maintains a "GOOD" Financial Health score, though current analysis suggests the stock may be trading above its Fair Value.
Analyst Eve Burstein noted that Agilent demonstrated its fifth consecutive quarter of sequential core revenue acceleration, with widespread improvement across business segments.
The company’s Analytical & Diagnostics (A&G) segment returned to 1% growth while the Pharmaceutical division saw 9% growth. The Environmental & Forensics segment was the only one to decline, down a modest 5%.
Bernstein highlighted management’s observation that approvals for capital expenditure purchases are coming more easily, with "reduced dependence on executive-level approvals that have slowed or stopped spending in the recent past."
Management commentary also indicated that pharmaceutical companies are not making cuts despite the uncertain environment, stating they’re "not seeing any concerns translate into negative impact around MFN or tariffs at all," which Bernstein considered "one of the most important messages" from the second quarter.
In other recent news, Agilent Technologies has reported its third-quarter earnings for 2025. The company met expectations with an earnings per share (EPS) of $1.37. Notably, Agilent’s revenue exceeded forecasts, reaching $1.74 billion compared to the anticipated $1.67 billion. These results highlight the company’s strong financial performance during this period.
Additionally, following the earnings release, Agilent’s stock saw a modest increase. Investors and analysts are likely to view these developments as a positive indicator of Agilent’s current market position. While the earnings figures were in line with projections, the revenue surpassing expectations is a key highlight for stakeholders. These recent developments underscore Agilent’s capability to deliver solid financial results.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.